# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001714899-26-000097
Filing Date
2026-08-06
Accepted
2026-08-06 16:08:18
Documents
78
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | dnli-20260630.htm iXBRL | 10-Q | 1122176
2 | EX-10.1 | exhibit101assetpurchaseagr.htm | EX-10.1 | 184436
3 | EX-31.1 | exhibit311q22026.htm | EX-31.1 | 9933
4 | EX-31.2 | exhibit312q22026.htm | EX-31.2 | 9953
5 | EX-32.1 | exhibit321q22026.htm | EX-32.1 | 5630
6 | EX-32.2 | exhibit322q22026.htm | EX-32.2 | 5759
| Complete submission text file | 0001714899-26-000097.txt |  | 6849176

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | dnli-20260630.xsd | EX-101.SCH | 47971
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | dnli-20260630_cal.xml | EX-101.CAL | 67501
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | dnli-20260630_def.xml | EX-101.DEF | 198668
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | dnli-20260630_lab.xml | EX-101.LAB | 599607
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | dnli-20260630_pre.xml | EX-101.PRE | 417999
82 | EXTRACTED XBRL INSTANCE DOCUMENT | dnli-20260630_htm.xml | XML | 906379

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8547
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38311 | Film No.: 261248985
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)